Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Caught in Traffic: Clot in Transit.
Gonzalez JM, Lowenhaar G, Chalasani P. Gonzalez JM, et al. Among authors: chalasani p. R I Med J (2013). 2024 Jun 3;107(6):10-11. R I Med J (2013). 2024. PMID: 38810007 Free article. No abstract available.
Burkholderia cepacia: A Rare Source of Endocarditis.
Gonzalez JM, Lowenhaar G, Ramgopal M, Chalasani P. Gonzalez JM, et al. Among authors: chalasani p. R I Med J (2013). 2024 Jan 4;107(1):23-25. R I Med J (2013). 2024. PMID: 38166072 Free article.
Triple Threat: Triple Pathogen Endocarditis.
Gonzalez JM, Lowenhaar G, Ramgopal M, Chalasani P. Gonzalez JM, et al. Among authors: chalasani p. Cureus. 2023 Oct 28;15(10):e47860. doi: 10.7759/cureus.47860. eCollection 2023 Oct. Cureus. 2023. PMID: 38021926 Free PMC article.
Transcranial Magnetic Stimulation for the Treatment of Chemo Brain.
Kuo PH, Chen AY, Rodriguez RJ, Stuehm C, Chalasani P, Chen NK, Chou YH. Kuo PH, et al. Among authors: chalasani p. Sensors (Basel). 2023 Sep 22;23(19):8017. doi: 10.3390/s23198017. Sensors (Basel). 2023. PMID: 37836847 Free PMC article. Clinical Trial.
Nuclear epidermal growth factor receptor as a therapeutic target.
Atwell B, Chalasani P, Schroeder J. Atwell B, et al. Among authors: chalasani p. Explor Target Antitumor Ther. 2023;4(4):616-629. doi: 10.37349/etat.2023.00156. Epub 2023 Aug 30. Explor Target Antitumor Ther. 2023. PMID: 37720348 Free PMC article. Review.
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
Coombes RC, Howell S, Lord SR, Kenny L, Mansi J, Mitri Z, Palmieri C, Chap LI, Richards P, Gradishar W, Sardesai S, Melear J, O'Shaughnessy J, Ward P, Chalasani P, Arkenau T, Baird RD, Jeselsohn R, Ali S, Clack G, Bahl A, McIntosh S, Krebs MG. Coombes RC, et al. Among authors: chalasani p. Nat Commun. 2023 Aug 7;14(1):4741. doi: 10.1038/s41467-023-40561-x. Nat Commun. 2023. PMID: 37550302 Free PMC article. No abstract available.
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
Coombes RC, Howell S, Lord SR, Kenny L, Mansi J, Mitri Z, Palmieri C, Chap LI, Richards P, Gradishar W, Sardesai S, Melear J, O'Shaughnessy J, Ward P, Chalasani P, Arkenau T, Baird RD, Jeselsohn R, Ali S, Clack G, Bahl A, McIntosh S, Krebs MG. Coombes RC, et al. Among authors: chalasani p. Nat Commun. 2023 Jul 24;14(1):4444. doi: 10.1038/s41467-023-40061-y. Nat Commun. 2023. PMID: 37488191 Free PMC article. Clinical Trial.
Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study.
Meric-Bernstam F, Calvo E, Lee KS, Moreno V, Park YH, Rha SY, Chalasani P, Zhong W, Zhou L, Pirie-Shepherd S, Leung ACF, Curigliano G. Meric-Bernstam F, et al. Among authors: chalasani p. Mol Cancer Ther. 2023 Oct 2;22(10):1191-1203. doi: 10.1158/1535-7163.MCT-23-0101. Mol Cancer Ther. 2023. PMID: 37420274 Free PMC article. Clinical Trial.
89 results